2025                      Elise-Richter-Fellow (Österreichischer Wissenschaftsfonds FWF)

2019-2021           Fördermittel der Friedrich-Schiller-Universität Jena (Deutschland)

2016-2017          Fellowship des Leibniz-Instituts für Altersfragen Jena (Deutschland)

2014-2015           Fellowship des Leibniz-Instituts für Altersfragen Jena (Deutschland)

2009-2011           Forschungsstipendium der Deutschen Pharmazeutischen Gesellschaft (DPhG) / Pharmaceutical Society of Japan (PSJ) und der Takeda Science Foundation für einen zweijährigen Forschungsaufenthalt an der Universität von Tokio (Japan)

2005                      Teilnahme an der „55. Tagung der Nobelpreisträger für Medizin, Chemie und Physik in Lindau“ (Deutschland)

Seit 2004             Mitglied der Deutschen Pharmazeutischen Gesellschaft (DPhG)

Seit 2009             Mitglied der Takeda Science Foundation

2010                    Mitglied der “Japanese Society of Neuroscience”

Seit 2018             Mitglied der Gesellschaft für Mineralstoffe und Spurenelemente (GMS)

Seit 2020              Mitglied der Herbal Medicinal Products Platform Austria (HMPPA)

Seit 2024             Board Member of the HMPPA

Seit 2024             Mitglied der Gesellschaft für Arzneipflanzen- und Naturstoffforschung (GA)

Seit 2024             Mitglied derÖsterreichische Pharmazeutische Gesellschaft (OePHG)

1. Koeberle, S. (2025) Decoding Ferroptosis: Natural product inspired drug discovery in degenerative disease, Meeting of the European Federation of Pharmaceutical Science (EUFEPS) (Vienna, Austria)

2. Koeberle, S. (2024) Uncovering redox-regenerating agents to combat ferroptosis INVITED TALK (University of MCLouvain (UCL), Brussels, Belgium).

3. Koeberle, S. (2024) Uncovering redox-regenerating agents to combat ferroptosis, INVITED TALK at the Lecture Series Cancer Biology (Ludwig-Maximilians-Universität München, München, Germany).

4. Koeberle, S. (2024) Utilizing FSP1 Oxidoreductase for Efficient Redox Regeneration of Radical Scavengers in Ferroptosis Protection, INVITED TALK at the Lecutures Series of the PhD Student/PostDoc Seminar of the SPP2306 Priority Program “Ferroptosis: from Molecular Basics to Clinical Applications”.

5. Koeberle, S. (2024) Utilizing FSP1 Oxidoreductase for Efficient Redox Regeneration of Radical Scavengers in Ferroptosis Protection, Austrian Summit on Natural Products (Seefeld, Austria).

6. Koeberle, S. (2023) Hijacking endogenous redox cycles to mitigate ferroptoticcell death, Annual Meeting of the German Pharmaceutical Society (DPhG) (Tübingen, Germany).

7. Koeberle, S. (2023) Manipulating endogenous redox systems to protect against ferroptotic cell death, Oral presentation at the Seminar "Current Discoveries in Biomedical Research" (Innsbruck, Austria).

8. Koeberle, S. (2023) Targeting lipid metabolism at the crossroad of different cell death programs, EMBO Workshop Ferroptosis: When metabolism meets cell death (Seeon- Seebruck, Germany).

9. Koeberle, S. (2022) To live or to die: Reprogramming cell fate with natural products, Meeting of the Center for Molecular Biosciences Innsbruck (CMBI) (Igls, Austria).

10. Koeberle, S. (2022) NRF2 cysteine code in ferroptosis and necroinflammation, INVITED TALK, Mini-Symposium: Michael Popp Institute, University of Innsbruck - German Cancer Research Center, Heidelberg. Cell death: metabolism, bioactive lipids and therapeutic strategies, VIRTUAL.

11. Koeberle, S. (2022) Selenium in NRF2 dependent redox signaling, INVITED TALK, International Conference of Trace Elements and Minerals (ICTEM) (Aachen, Germany).

12. Koeberle, S. (2021) Structural requirements of silybin from Silybum marianum that favourably shift fatty acids from triglycerides towards phospholipids in liver, INVITED TALK, HMPPA Symposium Milk Thistle: Phytochemical, pharmacological and clinical evidence, VIRTUAL.

13. Koeberle, S. (2021) Biogenic ferroptosis-modulating compounds: Challenges and opportunities in interfering with redox signalling and potential therapeutic applications, HMPPA Symposium “Next Generation in Pharmacognosy (Krems, Austria).

14. Koeberle, S. (2021) Redox-dependent regulation of inflammatory lipid mediator biosynthesis by glutathione peroxidases 1 and 2 as promising novel anti-inflammatory strategy, Highlight Talk, Annual Meeting of the German Pharmaceutical Society (DPhG), VIRTUAL.

15. Koeberle, S. (2021) The flavonolignan silybin from Silybum marianum targets hepatic lipid biosynthesis and elevates the hepatic biotransformation capacity, Society for Medicinal Plant and Natural Product Research (GA) Annual Meeting, VIDEO CONTRIBUTION.

16. Koeberle, S. (2021) Glutathione peroxidases 1 and 2 as promising targets in anti-inflammatory therapy, Highlight Talk, Meeting of the European Federation of Pharmaceutical Science (EUFEPS), VIRTUAL.

17. Koeberle, S. (2021) Glutathione peroxidases – Novel targets of anti-inflammatory drugs? Highlight Talk, Frontiers in Medicinal Chemistry, VIRTUAL.

18. Koeberle, S. (2021) Impact of the trace element selenium on macrophages during differentiation, Scientific Congress of the German Society of Nutrition (DGE), VIRTUAL.

19. Koeberle, S. (2020) Selenoproteins in redox-dependent inflammatory signaling, Seminar series “Current research results in Pharmacy“ (University of Innsbruck, VIRTUAL).

20. Koeberle, S. (2012) Forgotten neuronal signaling mechanisms: Importance of contact-dependent processes in brain development, Leibniz Institute on Aging (Jena, Germany).

21. Koeberle, S. (2011) What is the role of the tumor suppressor gene NF2 in the brain during development? Leibniz Institute on Aging Evaluation (Jena, Germany).

22. Koeberle, S. (2011) Role of CaMKIIα activity in spine formation and morphology during development, INVITED TALK, Leibniz Institute on Aging (Jena, Germany).

23. Koeberle, S. (2010) Role of CaMKIIα activity in spine formation and dendritic arborisation during development, Joint Workshop, University of Tokyo, (Tokyo, Japan).

24. Koeberle, S. (2009) Synthese und biologische Testung neuer aza-analoger und disubstituierter Dibenzepinone als Hemmstoffe der p38 MAP, University of Tübingen (Tübingen, Germany).

25. Koeberle, S. (2005) Synthese von Dibenzosuberonderivaten als allosterische p38 MAP Kinase Inhibitoren, University of Tübingen (Tübingen, Germany).

2021 Beitrag zur Neugestaltung des Bereichs „Arzneipflanzen“ und „Nutzpflanzen“ des Botanischen Gartens in Innsbruck

•       Nature (IF 64.8)

•       Cancer Communications (IF 16.8)

•       Theranostics (IF 12.4) 

•       British Journal of Pharmacology (IF 8.7)

•       International Journal of Molecular Science (IF 6.2)

•       Food and Chemical Toxicology (IF 5.6)

•       BioMed Research International (IF 3.4)